Showing results (1-10 of 112) with videos related to
Sort By:
Pageof 12
Breast Cancer Research : BCR|April 24, 2015
Molecular characterization and targeted therapeutic approaches in breast cancerAngela Toss, Massimo CristofanilliJournal of Personalized Medicine|April 3, 2021
Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors?Laura Cortesi, Claudia Piombino, Angela TossRecenti Progressi in Medicina|January 22, 2026
[Trastuzumab-deruxtecan (T-DXd) in HER2+ metastatic breast cancer: efficacy, clinical management, and perspectives.]Fabio Canino, Mario Giuliano, Angela TossCurrent Cancer Drug Targets|March 10, 2018
PARP Inhibitors for the Treatment of Ovarian CancerLaura Cortesi, Angela Toss, Iole CucinottoAnnals of Translational Medicine|December 10, 2014
CTC enumeration and characterization: moving toward personalized medicineAngela Toss, Zhaomei Mu, Sandra Fernandez, et al.Tumori|April 27, 2026
Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics DaysLorenzo Belluomini, Angela Toss, Massimo Di Maio, et al.Frontiers in Oncology|June 6, 2022
Management of HER2-Positive Early Breast Cancer in Italy: A Maze Presenting Opportunities and ChallengesLuigia Stefania Stucci, Marco Pisino, Claudia D'Addario, et al.International Journal of Molecular Sciences|January 6, 2017
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?Angela Toss, Marta Venturelli, Chiara Peterle, et al.Journal of Oncology|August 1, 2020
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCAClaudia Piombino, Laura Cortesi, Matteo Lambertini, et al.Expert Opinion on Drug Safety|July 11, 2020
Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which?Giovanni Grandi, Martina Caroli, Laura Cortesi, et al.Pageof 12